86 related articles for article (PubMed ID: 22990105)
1. Identification of differentially expressed proteins from primary versus metastatic pancreatic cancer cells using subcellular proteomics.
McKinney KQ; Lee JG; Sindram D; Russo MW; Han DK; Bonkovsky HL; Hwang SI
Cancer Genomics Proteomics; 2012; 9(5):257-63. PubMed ID: 22990105
[TBL] [Abstract][Full Text] [Related]
2. Discovery of putative pancreatic cancer biomarkers using subcellular proteomics.
McKinney KQ; Lee YY; Choi HS; Groseclose G; Iannitti DA; Martinie JB; Russo MW; Lundgren DH; Han DK; Bonkovsky HL; Hwang SI
J Proteomics; 2011 Jan; 74(1):79-88. PubMed ID: 20807598
[TBL] [Abstract][Full Text] [Related]
3. Proteome analysis of human pancreatic cancer cell lines with highly liver metastatic potential by antibody microarray.
Shi W; Meng Z; Chen Z; Luo J; Liu L
Mol Cell Biochem; 2011 Jan; 347(1-2):117-25. PubMed ID: 20960035
[TBL] [Abstract][Full Text] [Related]
4. Subcellular proteomics: determination of specific location and expression levels of lymphatic metastasis associated proteins in hepatocellular carcinoma by subcellular fractionation.
Qazi AS; Sun M; Huang Y; Wei Y; Tang J
Biomed Pharmacother; 2011 Sep; 65(6):407-16. PubMed ID: 21741201
[TBL] [Abstract][Full Text] [Related]
5. Selecting targets for therapeutic validation through differential protein expression using chromatography-mass spectrometry.
Patterson S
Bioinformatics; 2002; 18 Suppl 2():S181. PubMed ID: 12386001
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma.
Kuo KK; Kuo CJ; Chiu CY; Liang SS; Huang CH; Chi SW; Tsai KB; Chen CY; Hsi E; Cheng KH; Chiou SH
Pancreas; 2016 Jan; 45(1):71-83. PubMed ID: 26262590
[TBL] [Abstract][Full Text] [Related]
7. In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion.
Barderas R; Mendes M; Torres S; Bartolomé RA; López-Lucendo M; Villar-Vázquez R; Peláez-García A; Fuente E; Bonilla F; Casal JI
Mol Cell Proteomics; 2013 Jun; 12(6):1602-20. PubMed ID: 23443137
[TBL] [Abstract][Full Text] [Related]
8. Identification of markers associated with highly aggressive metastatic phenotypes using quantitative comparative proteomics.
Terp MG; Lund RR; Jensen ON; Leth-Larsen R; Ditzel HJ
Cancer Genomics Proteomics; 2012; 9(5):265-73. PubMed ID: 22990106
[TBL] [Abstract][Full Text] [Related]
9. Combined miRNA profiling and proteomics demonstrates that different miRNAs target a common set of proteins to promote colorectal cancer metastasis.
Torres S; Garcia-Palmero I; Bartolomé RA; Fernandez-Aceñero MJ; Molina E; Calviño E; Segura MF; Casal JI
J Pathol; 2017 May; 242(1):39-51. PubMed ID: 28054337
[TBL] [Abstract][Full Text] [Related]
10. Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice.
Suemizu H; Monnai M; Ohnishi Y; Ito M; Tamaoki N; Nakamura M
Int J Oncol; 2007 Oct; 31(4):741-51. PubMed ID: 17786304
[TBL] [Abstract][Full Text] [Related]
11. A new liver metastatic and peritoneal dissemination model established from the same human pancreatic cancer cell line: analysis using cDNA macroarray.
Nomura H; Nishimori H; Yasoshima T; Hata F; Tanaka H; Nakajima F; Honma T; Araya J; Kamiguchi K; Isomura H; Sato N; Denno R; Hirata K
Clin Exp Metastasis; 2002; 19(5):391-9. PubMed ID: 12198767
[TBL] [Abstract][Full Text] [Related]
12. Distinct Protein Expression Profiles of Solid-Pseudopapillary Neoplasms of the Pancreas.
Park M; Lim JS; Lee HJ; Na K; Lee MJ; Kang CM; Paik YK; Kim H
J Proteome Res; 2015 Aug; 14(8):3007-14. PubMed ID: 26148796
[TBL] [Abstract][Full Text] [Related]
13. Quantitative secretomic analysis of pancreatic cancer cells in serum-containing conditioned medium.
Liu P; Weng Y; Sui Z; Wu Y; Meng X; Wu M; Jin H; Tan X; Zhang L; Zhang Y
Sci Rep; 2016 Nov; 6():37606. PubMed ID: 27869176
[TBL] [Abstract][Full Text] [Related]
14. Identification of differentially expressed proteins in pancreatic cancer using a global proteomic approach.
Rosty C; Goggins M
Methods Mol Med; 2005; 103():189-97. PubMed ID: 15542907
[TBL] [Abstract][Full Text] [Related]
15. Comparative Proteomic Profiling of Extracellular Proteins between Normal and Gastric Cancer Cells.
Kang M; Lu S; Chong PK; Yeoh KG; Lim YP
Curr Cancer Drug Targets; 2016; 16(5):442-54. PubMed ID: 26648486
[TBL] [Abstract][Full Text] [Related]
16. Expression and Significances of MTSS1 in Pancreatic Cancer.
Zhou L; Li J; Shao QQ; Guo JC; Liang ZY; Zhou WX; Zhang TP; You L; Zhao YP
Pathol Oncol Res; 2016 Jan; 22(1):7-14. PubMed ID: 26198729
[TBL] [Abstract][Full Text] [Related]
17. Reverse-phase protein array analysis to identify biomarker proteins in human pancreatic cancer.
Huang YJ; Frazier ML; Zhang N; Liu Q; Wei C
Dig Dis Sci; 2014 May; 59(5):968-75. PubMed ID: 24248418
[TBL] [Abstract][Full Text] [Related]
18. Identification of dissociation factors in pancreatic Cancer using a mass spectrometry-based proteomic approach.
Liu P; Kong L; Liang K; Wu Y; Jin H; Song B; Tan X
BMC Cancer; 2020 Jan; 20(1):45. PubMed ID: 31959150
[TBL] [Abstract][Full Text] [Related]
19. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
20. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
